Former BNP Sunstone chairman joins cancer vaccine firm’s board
The former chairman of BNP Sunstone and a pharmaceutical veteran has joined the board of a firm developing a cancer vaccine. Martyn Greenacre has served as a CEO of Delsys Pharmaceutical Corp., a formulation and drug-delivery system company later acquired by Elan. He worked in the European division of SmithKline Beecham in several roles that […]